The Czech Republic Annual Report 2010 Drug ... - Drogy-info.cz

Table 9-10: Criminal offences committed under the influence of addictive substances in 2009–2010..............................124
Table 9-11: Number of persons ordered to undergo outpatient or institutional compulsory drug/alcohol treatment in the
period 2004–2009 .....................................................................................................................................................125
Table 9-12: Number of drug-related offences under Sections 187–188a of the old Penal Code and under Sections 283,
284, 286, and 287 of the new Penal Code, respectively, recorded for prisoners at the end of 2008, 2009, and 2010
. .................................................................................................................................................................................126
Table 9-13: Number, capacity, and use of drug-free zones and specialised departments in Czech prisons in 2006–2010
..................................................................................................................................................................................129
Table 9-14: Prisons providing substitution therapy, number of persons in therapy, and average duration of therapy in
2010. .........................................................................................................................................................................129
Table 9-15: NGOs providing drug services in prison, prisons where these NGOs operate, and number of visits and
interventions carried out in 2010. ..............................................................................................................................130
Table 10-1: Structure of the marijuana market – quantities sold and selling prices...........................................................132
Table 10-2: Shops selling new synthetic drugs (legal highs) in the Czech Republic in April 2011 ...................................135
Table 10-3: Number of seizures and quantities of main drug types seized in 2007–2010. ...............................................137
Table 10-4: Seizures of pervitin precursors, pervitin cooking labs, and pervitin in the period 2007–2010 ........................137
Table 10-5: Average and most commonly reported (modus) prices of drugs in 2007–2010 (€)........................................138
Table 10-6: Average drug purity in 2007–2010, in %. .......................................................................................................138
Table 12-1: All drug users in treatment living with children, according to gender and age, Czech Republic, 2010 ...........150
Table 12-2: Total number of mothers giving birth and the number of mothers recorded as using addictive substances at
the time of their giving birth, including their average age, in the years 2000–2009 ...................................................152
Table 12-3: Health characteristics of newborns in total and of children born to substance-using mothers, 2000–2009....153
Table 13-1: Hospitalisations of foreigners for disorders caused by the use of substances other than alcohol and tobacco
(dg. F11–F19, excl. F17) according to their EU affiliation status and Czech Republic residency status, 2005–10 ...158
Table 13-2: Hospitalisations of foreigners for disorders caused by the use of substances other than alcohol and tobacco
(dg. F11–F19, excl. F17) according to their EU affiliation status and gender, 2005–2010 ........................................159
Table 13-3: Foreigners among all drug treatment demands according to citizenship, 2005–2010....................................159
Table 13-4: Foreigners among all drug treatment demands according to drug of choice, 2005–2010, in %.....................159
Table 13-5: Foreigners among all drug treatment demands according to route of administration, 2005–2010, in % ........159
LIST OF FIGURES
Figure 2-1: Comparison of prevalence rates of the use of illegal drugs as recorded by selected surveys from the period
2008–2010, for the 15–64 age group, in % .................................................................................................................31
Figure 2-2: Agreement with criminal sanctions for selected activities, in % ........................................................................36
Figure 2-3: Public attitudes to the legalisation of marijuana according to the 2010 SANEP survey, in % ...........................36
Figure 2-4: Trends in prevalence rates of cannabis use among the population of 15-year-olds recorded by the HBSC
surveys in the years 2002, 2006, and 2010, in %........................................................................................................38
Figure 2-5: Lifetime prevalence of use of selected drugs among dance partygoers in 2000, 2003, 2007, and 2010, in % .39
Figure 3-1: Posters placed in Prague in September and October 2010 highlighting the conference Urban Drug Policies in
the Globalised World...................................................................................................................................................46
Figure 4-1: Mean values and 95% confidence intervals of prevalence estimates of problem drug use carried out using the
multiplication method with the use of data from low-threshold programmes in 2002–2010.........................................49
Figure 5-1: Quantity of buprenorphine (g) distributed in individual medicinal products in 2008–2010.................................61
Figure 5-2: Overlap of problem Subutex ® users and substitution treatment patients using buprenorphine-based products
in 2009–2010, estimate based on available data ........................................................................................................65
Figure 5-3: Number of first-time treatment demands according to drug used in 1997–2010...............................................73
Figure 5-4: Number of all treatment demands according to drug used in 2002–2010.........................................................73
Figure 5-5: Average age of first-time treatment demands according to selected drugs in 1997–2010................................74
Figure 5-6: Average age of all treatment demands according to selected drugs in 2002–2010..........................................75
Figure 5-7: Selected characteristics of first treatment demands in 1997–2010...................................................................75
Figure 5-8: Selected characteristics of all treatment demands in 2002–2010 .....................................................................76
Figure 5-9: Trends in the number of clients in substitution treatment by region of permanent residence in 2008–2010 .....79
Figure 5-10: Trends in the capacity of sobering-up stations and the number of patients treated in 1989–2010 .................80
Figure 6-1: Reported incidence of acute HBV among all patients and injecting drug users in the Czech Republic in 1996–
2010 ............................................................................................................................................................................84
Figure 6-2: Reported incidence of acute and chronic HCV among all patients and injecting drug users in the Czech
Republic in 1996–2010................................................................................................................................................84
Figure 6-3: Average age of injecting drug users with reported HBV and HCV in 1997–2010 .............................................85
Figure 6-4: Reported incidence of HAV among all patients and injecting drug users in the Czech Republic in 1996–201085
Figure 6-5: Reported incidence of syphilis and gonorrhea among all patients and among injecting drug users in the
Czech Republic in 2000–2010 ....................................................................................................................................86
Figure 6-6: Reported incidence of tuberculosis among all patients and among users of alcohol and other drugs in the
Czech Republic, 1997–2010 .......................................................................................................................................87
Figure 6-7: Proportion of injecting drug use among first-time treatment demands and all treatment demands related to
heroin, Subutex ® , and pervitin use, in % .....................................................................................................................91
Figure 6-8: Trends in the proportion of injecting heroin, pervitin, and polydrug users treated at outpatient psychiatric
facilities, 1997–2010, in %...........................................................................................................................................91
Figure 6-9: Fatal overdoses from benzodiazepines, illegal drugs, and inhalants, 1998–2010 ............................................97
page 164